Search Results
Jan 27, 2026, 08:55 ET New Research Suggests Lion's Mane Mushroom Mycelium Supports a 'Smarter' Immune Response Compared to Fruiting Body-Only Extracts*
balancing—not by working harder but by working smarter.*"This research shows that not all Lion's Mane products are created equal," said Chase Beathard, PhD, MBA, Associate Director of Research and Development for Host Defense and lead author of the study. "How the mushroom is grown and prepared matters—and
More news about: Fungi Perfecti, LLC
Jan 27, 2026, 08:51 ET Dale Carnegie Report Finds Organizational Health Improving, but Gaps in Key Areas Persist
accelerates."Our research shows that organizations are making significant gains in how people connect and communicate at work," said study author, Robert Coleman, PhD, director of research and thought leadership for Dale Carnegie. "But progress is uneven. When trust, leadership consistency, and employee support struggle
More news about: Dale Carnegie
Jan 27, 2026, 08:00 ET SimBioSys Appoints Senthil Periaswamy as Chief AI & Technology Officer
an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today announced the appointment of Senthil Periaswamy, PhD, as Chief AI & Technology Officer. In this newly created role, Dr. Periaswamy will lead SimBioSys' AI strategy, technology vision, and scientific
More news about: SimBioSys
Jan 27, 2026, 08:00 ET Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
indications is significant, with a Total Addressable Market of $3.8 billion[6]."Professor Evangelos J. Giamarellos-Bourboulis, M.D., PhD, at the 4th Department of Internal Medicine, ATTIKON University General Hospital, Athens, Greece, and co-author of the paper said: "Hidradenitis
More news about: VolitionRx Limited
Jan 27, 2026, 06:00 ET Prominent Data Scientist Joins Online Broker TradingBlock as Chief Innovation Officer
TradingBlock today announced that prominent data scientist Michael "Dr. Data" Rechenthin, PhD, has joined the company as Chief Innovation Officer to lead the firm's AI, big-data analytics and quantitative research initiatives, and the advancement
More news about: TradingBlock
Jan 26, 2026, 17:27 ET 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
planning, and longitudinal monitoring."This is an extraordinarily important and validating event for multiple reasons," says Andreas Fouras, PhD, 4DMedical Founder and CEO. "First, it reflects growing global recognition of the technological leadership of 4DMedical, including our groundbreaking
More news about: 4DMedical
Jan 26, 2026, 16:14 ET NucleicAI Appoints Former Broad Institute Engineer Douglas Voet as Principal Engineering Architect
precision medicine, and longevity initiatives.""We are thrilled to welcome Douglas to the NucleicAI team," said Dr. David Sinclair, AO, PhD, Co-Founder of NucleicAI and Professor of Genetics at Harvard Medical School. "His ability to translate complex biological data into actionable intelligence
More news about: NucleicAI
Jan 26, 2026, 14:30 ET Study Shows NanoFuse® Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone
composite, materials-based approach to bone regeneration.Independent Expert Perspective on Bioactive Ion SynergyDr. Martin Crous, PhD , a recognized leader in osteobiologics research, viewed the findings as an important validation of materials-driven osteoinduction."This study
More news about: NanoFUSE Biologics
Jan 26, 2026, 09:00 ET New Survey Signals National Nutrition Crisis as Misinformation Outpaces Evidence-Based Care
every part of our lives, yet there is a major lack of public knowledge about who nutrition and dietetics professionals are," said Wylecia Wiggs Harris, PhD, CAE, Chief Executive Officer of the Academy. "This campaign raises awareness of registered dietitian nutritionists (RDNs) and nutrition and dietetics
More news about: Academy of Nutrition & Dietetics
Jan 26, 2026, 08:30 ET Immusoft Receives FDA Rare Pediatric Disease Designation for ISP-002 to treat Mucopolysaccharidosis Type II
develop their engineered B cell platform in both MPS I and II and help those patients who are living with this debilitating disease," said Lisa Kadyk, PhD, CIRM Fellow, Clinical Development at the California Institute for Regenerative Medicine. "Benefiting patients with no other options is the core mission
More news about: Immusoft
Jan 26, 2026, 08:01 ET START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site
Chris Takimoto, MD, PhD, Chief Medical Officer at START. "His expertise strengthens an already exceptional group of investigators across the START Network and enhances our
More news about: The START Center for Cancer Research
Jan 26, 2026, 07:35 ET Super Bowl Advertising Expert Available: What to Watch for in 2026 Ads -- From AI's Breakthrough Moment to America's 250th Anniversary
assess brand impact, and explain what separates ads that entertain from those that deliver long-term brand value.Who: Charles R. Taylor, PhD, is a nationally recognized expert on advertising and marketing with deep expertise in Super Bowl advertising. He is editor of the
More news about: Villanova School of Business
Jan 25, 2026, 23:30 ET ATTORNEY GENERAL R. VENKATARAMANI, RELIANCE INDUSTRIES EXECUTIVE DIRECTOR HITAL MESWANI RECEIVE HONORARY DOCTORATES AT AMITY UNIVERSITY MAHARASHTRA CONVOCATION
University celebrates 1,521 graduates, including 25 PhD scholars and 151 medal winners, at Shanmukhanand Auditorium ceremonyMUMBAI, India, Jan. 26, 2026 /PRNewswire/ -- Attorney General of India R. Venkataramani
More news about: Amity University Maharashtra
Jan 25, 2026, 20:34 ET Columbia University Names Jennifer L. Mnookin as Next President
public decision-making and serves the broader public good.Mnookin received her AB from Harvard University, her JD from Yale Law School, and a PhD in history and social study of science and technology from MIT. She and her husband, political scientist Joshua Foa Dienstag, have two children.
More news about: Columbia University
Jan 23, 2026, 17:32 ET /C O R R E C T I O N -- Privo Technologies/
removed and access is optimal."This study represents an important step forward in our approach to cancer surgery," said Dr. Manijeh Goldberg, PhD, Founder and CEO of Privo Technologies. "PRV211 is customized medicine that enables surgeons to deliver targeted treatment precisely where recurrence
More news about: Privo Technologies
Jan 23, 2026, 10:00 ET HCI Announces SPARK HR 2026 in St. Pete Beach, FL on April 28-30, 2026: A Transformative Conference on Employee Experience, Leadership & the Future of Work
long-term professional relationships."Even as AI transforms the workplace, what drives engagement remains profoundly human," explains Adam Hickman, PhD., Vice President of Organizational and Employee Development at The Walt Disney Company. "At SPARK HR, I look forward to sharing how leaders can meet the
More news about: Human Capital Institute
Jan 23, 2026, 09:00 ET Cook County Treasurer Maria Pappas recognizes Assyrian National Heritage by honoring more than two dozen civic, business and community leaders
Sargool, Niles Township HS Teacher, Fr. Gewargis Shmoel, St. Odisho Church & Assyrian Church of the East, Stephanie Sorisho, Indiana University PhD Candidate, Rabi Joann Yousif, Assyrian National Council of Illinois Principal
More news about: Cook County Treasurer Maria Pappas
Jan 23, 2026, 08:30 ET Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
via our AI-powered design process, offers the potential to advance Parkinson's Disease treatment to the next generation," says Carol Satler, MD, PhD, Senior Vice President for Clinical Development, Non-Oncology, Insilico Medicine. "We are excited to get the greenlight from FDA to advance this
More news about: Insilico Medicine
Jan 22, 2026, 16:48 ET UNLIKELY COLLABORATORS ANNOUNCES FIRST-EVER SUNDAY SPARK SALON FEATURING WENDY SUZUKI, PhD: "HARNESSING THE POWER OF GOOD ANXIETY"
Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author Michael Norton, PhD, visionary violinist Vijay Gupta, chef and entrepreneur Ellen Bennett, artist Candy Chang, digital workplace expert and author Alexandra Samuel, PhD, grief experts
More news about: Unlikely Collaborators
Jan 22, 2026, 13:53 ET NOW! Programs® Enables Literacy Skills That Unlock Workforce and Academic Pathways
NOW! Programs®, founded by Dr. Tim Conway, PhD, CEO, reported nationally recognized student outcomes from 2025 that highlight the role of foundational literacy skills in workforce
More news about: NOW! Programs®
Jan 22, 2026, 13:04 ET Arbor Scientia Group Introduces an Innovative Educational Strategy to Assist Their Pharmaceutical Clients in Driving Measurable Learning Outcomes
the ultimate goal of improving patient lives.Founded by internationally renowned psychiatrist and professor of psychiatry Stephen M. Stahl, MD, PhD, DSc (Hon), DMedSci (Hon, Cambridge), and current CEO Richard Davis, an adult learning and communications expert, ASG sets themselves apart in the agency
More news about: Arbor Scientia Group
Jan 22, 2026, 12:30 ET Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)
represents an important validation of the trial findings and highlights the significance of chronic cough in patients with IPF," said James Cassella, PhD, Chief Development Officer of Trevi Therapeutics. "The statistically-significant reduction in 24-hour objective cough frequency across all dose groups
More news about: Trevi Therapeutics, Inc.
Jan 22, 2026, 11:12 ET Replacing Microbiota Makes Aging Intestines Young Again
studySeveral other Cincinnati Children's experts collaborated on this study, including first author Kodandaramireddy Nalapareddy, PhD, David Haslam, MD, and Theresa Alenghat, VMD, PhD. The Research Flow Cytometry Facility and the Comprehensive Mouse and Cancer Core at Cincinnati Children's also contributed
More news about: Cincinnati Children's Hospital Medical Center
Jan 22, 2026, 11:05 ET PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials
for complex IBD studies."Our solution shifts clinical operations from reactive monitoring to dynamic trial optimization," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "By applying causal ML to granular patient- and site-level data, we allow sponsors to treat every covariate as an operational
More news about: PhaseV
Jan 22, 2026, 09:37 ET Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
Mistral) to reason in medicinal chemistry, biology, and clinical development with the precision required in modern pharma R&D.Alex Zhavoronkov, PhD, founder, CEO and CBO of Insilico Medicine invites pharma and biotech companies, AI labs, and cloud providers to "bring your AI model to Science MMAI
More news about: Insilico Medicine